Top Markets
#1 Islamic Coin Islamic Coin +151.32%
#2 Akedo Akedo +76.22%
#3 Glidr Glidr +51.75%
#4 DOVU DOVU +48.30%
#5 Velvet Velvet +34.72%
#6 Black Phoenix Black Phoenix +34.06%
#7 Cross Cross +32.03%
#8 Cap Cap +22.74%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.58%
#10 DoubleZero DoubleZero +14.87%
Coin of the day
Islamic Coin Islamic Coin
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Burzynski Research Institute, Inc. Burzynski Research Institute, Inc.

Burzynski Research Institute, Inc.

BZYR
Rangering i aksjer #39234
Burzynski Research Institute, Inc. engages in the research and development of... Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. The company was founded in 1977 and is headquartered in Houston, Texas.
Aksjekurs
$0.0045
Sist synkronisert: 2026-08-13
Markedsverdi
$591.52K
Endring (1 dag)
-10.00%
Endring (1 år)
-86.76%
Land
US
Handel Burzynski Research Institute, Inc. (BZYR)

Kategori

Healthcare
Inntekter for Burzynski Research Institute, Inc. (BZYR)
Inntekter i 2026 TTM: 0
Ifølge Burzynski Research Institute, Inc. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Burzynski Research Institute, Inc. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US